Disclosed herein are novel siRNA-cochleate and morpholino-cochleate compositions.

Also disclosed are methods of making and using siRNA-cochleate and morpholino-cochleate compositions.

A cochlear implant electrode arrangement is described.

A cochlear implant device is described which is an electrode shell for insertion into a fixed position in cochlear tissue.

Alternatively, the cochlear implant includes two modular units.

A preferred cochleate contains the antifungal agent amphotericin B.

An electrode array for use with a cochlear implant is disclosed, which has electrodes selectively spaced to better target selected regions of the cochlea.

The implantable lead may be used in a cochlear implant.

One stream is the ventral cochlear nucleus which is split further into the posteroventral cochlear nucleus (PVCN) and the anteroventral cochlear nucleus (AVCN).

A cochlear implant system is a combination of an internal cochlear implant and an external audio processor.

A cochlear implant consists of an external sound processor and an internal cochlear implant.

An electrode guide bridge is used for inserting a cochlear implant electrode into a cochlea scala of a patient cochlea.

The corrected information is then used as control signal for the cochlea implant, or the control signal is derived from the corrected information.

Cochlear implantation: a cochlear implant is a small electronic device that assists people in hearing.

One example of such a prosthesis being a cochlear implant.